{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T18:38:08Z","timestamp":1775155088555,"version":"3.50.1"},"reference-count":170,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T00:00:00Z","timestamp":1673222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011776","name":"Instituto Portugu\u00eas de Oncologia do Porto","doi-asserted-by":"publisher","award":["CI-IPOP-FBGEBC-27 CI-IPOP-PI-137"],"award-info":[{"award-number":["CI-IPOP-FBGEBC-27 CI-IPOP-PI-137"]}],"id":[{"id":"10.13039\/501100011776","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["AIRC IG17217"],"award-info":[{"award-number":["AIRC IG17217"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009448","name":"Universit\u00e0 degli Studi della Campania Luigi Vanvitelli","doi-asserted-by":"publisher","award":["2020-UNA2CLE-0203198"],"award-info":[{"award-number":["2020-UNA2CLE-0203198"]}],"id":[{"id":"10.13039\/501100009448","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["CEECINST\/00091\/2018"],"award-info":[{"award-number":["CEECINST\/00091\/2018"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"abstract":"<jats:p>Bladder cancer (BlCa) is a highly immunogenic cancer. Bacillus Calmette-Gu\u00e9rin (BCG) is the standard treatment for non-muscle invasive bladder cancer (NMIBC) patients and, recently, second-line immunotherapies have arisen to treat metastatic BlCa patients. Understanding the interactions between tumor cells, immune cells and soluble factors in bladder tumor microenvironment (TME) is crucial. Cytokines and chemokines released in the TME have a dual role, since they can exhibit both a pro-inflammatory and anti-inflammatory potential, driving infiltration and inflammation, and also promoting evasion of immune system and pro-tumoral effects. In BlCa disease, 70\u201380% are non-muscle invasive bladder cancer, while 20\u201330% are muscle-invasive bladder cancer (MIBC) at the time of diagnosis. However, during the follow up, about half of treated NMIBC patients recur once or more, with 5\u201325% progressing to muscle-invasive bladder cancer, which represents a significant concern to the clinic. Epithelial-mesenchymal transition (EMT) is one biological process associated with tumor progression. Specific cytokines present in bladder TME have been related with signaling pathways activation and EMT-related molecules regulation. In this review, we summarized the immune landscape in BlCa TME, along with the most relevant cytokines and their putative role in driving EMT processes, tumor progression, invasion, migration and metastasis formation.<\/jats:p>","DOI":"10.3389\/fmolb.2022.1070383","type":"journal-article","created":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T08:51:22Z","timestamp":1673254282000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["Tumor microenvironment and epithelial-mesenchymal transition in bladder cancer: Cytokines in the game?"],"prefix":"10.3389","volume":"9","author":[{"given":"Cl\u00e1udia","family":"Martins-Lima","sequence":"first","affiliation":[]},{"given":"Ugo","family":"Chianese","sequence":"additional","affiliation":[]},{"given":"Rosaria","family":"Benedetti","sequence":"additional","affiliation":[]},{"given":"Lucia","family":"Altucci","sequence":"additional","affiliation":[]},{"given":"Carmen","family":"Jer\u00f3nimo","sequence":"additional","affiliation":[]},{"given":"Margareta P.","family":"Correia","sequence":"additional","affiliation":[]}],"member":"1965","published-online":{"date-parts":[[2023,1,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"5060","DOI":"10.1158\/1078-0432.CCR-08-2245","article-title":"miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy","volume":"15","author":"Adam","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"5269","DOI":"10.4049\/jimmunol.165.9.5269","article-title":"The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity","volume":"165","author":"Addison","year":"2000","journal-title":"J. Immunol."},{"key":"B3","article-title":"Urinary IL-8 and BLCA-4 in detection of bladder cancer and their clinical significant","volume":"8","author":"Al-biaty","year":"2015","journal-title":"Iraqi J. Cancer Med. Genet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1046\/j.1464-410x.1998.00675.x","article-title":"Urinary levels of monocyte chemo-attractant protein-1 correlate with tumour stage and grade in patients with bladder cancer","volume":"82","author":"Amann","year":"1998","journal-title":"Br. J. Urol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1097\/00005392-200203000-00083","article-title":"Preoperative plasma levels of interleukin-6 and its soluble receptor predict disease recurrence and survival of patients with bladder cancer","volume":"167","author":"Andrews","year":"2002","journal-title":"J. Urology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"4244","DOI":"10.1158\/0008-5472.CAN-06-3946","article-title":"Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium","volume":"67","author":"Ao","year":"2007","journal-title":"Cancer Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e05556","DOI":"10.1016\/j.heliyon.2020.e05556","article-title":"Prognostic significance of CD4-positive regulatory T cells in tumor draining lymph nodes from patients with bladder cancer","volume":"6","author":"Ariafar","year":"2020","journal-title":"Heliyon"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1073\/pnas.1611958114","article-title":"Essential role of immobilized chemokine CXCL12 in the regulation of the humoral immune response","volume":"114","author":"Barinov","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B9","first-page":"3537","article-title":"Immunohistochemical evaluation of CXCL12-CXCR4 axis and VEGFR3 expression in primary urothelial cancer and its recurrence","volume":"34","author":"Batsi","year":"2014","journal-title":"Anticancer Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.3892\/ijo.2013.2065","article-title":"Mutation of TGF-\u03b2 receptor II facilitates human bladder cancer progression through altered TGF-\u03b21 signaling pathway","volume":"43","author":"Bian","year":"2013","journal-title":"Int. J. Oncol."},{"key":"B11","first-page":"456","article-title":"The role of interleukin-8 in inflammation and mechanisms of regulation","volume":"64","author":"Bickel","year":"1993","journal-title":"J. Periodontol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1093\/intbio\/zyz021","article-title":"NRF2 activates a partial epithelial-mesenchymal transition and is maximally present in a hybrid epithelial\/mesenchymal phenotype","volume":"11","author":"Bocci","year":"2019","journal-title":"Integr. Biol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.4049\/jimmunol.1700129","article-title":"CXCL1 and CXCL2 regulate NLRP3 inflammasome activation via G-protein\u2013coupled receptor CXCR2","volume":"199","author":"Boro","year":"2017","journal-title":"J. Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/1097-0215(20010601)92:5<697:aid-ijc1245>3.0.co;2-z","article-title":"NK cells are essential for effective BCG immunotherapy","volume":"92","author":"Brandau","year":"2001","journal-title":"Int. J. Cancer"},{"key":"B15","doi-asserted-by":"publisher","first-page":"20140042","DOI":"10.1098\/rstb.2014.0042","article-title":"Cell adhesion and urothelial bladder cancer: The role of cadherin switching and related phenomena","volume":"370","author":"Bryan","year":"2015","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"9804","DOI":"10.3390\/ijms22189804","article-title":"Chemokine-directed tumor microenvironment modulation in cancer immunotherapy","volume":"22","author":"Bule","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1186\/s40064-015-1393-9","article-title":"CXCL1 is elevated in the urine of bladder cancer patients","volume":"4","author":"Burnier","year":"2015","journal-title":"Springerplus"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.3389\/fonc.2019.01533","article-title":"Screening and identifying immune-related cells and genes in the tumor microenvironment of bladder urothelial carcinoma: Based on TCGA database and bioinformatics","volume":"9","author":"Cao","year":"2019","journal-title":"Front. Oncol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1111\/jcmm.14767","article-title":"An EMT-related gene signature for the prognosis of human bladder cancer","volume":"24","author":"Cao","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s11934-018-0853-5","article-title":"Molecular characterization of bladder cancer","volume":"19","author":"Chandrasekar","year":"2018","journal-title":"Curr. Urol. Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1901399","DOI":"10.1002\/adhm.201901399","article-title":"Distinguishing specific CXCL12 isoforms on their angiogenesis and vascular permeability promoting properties","volume":"9","author":"Chang","year":"2020","journal-title":"Adv. Healthc. Mat."},{"key":"B22","doi-asserted-by":"publisher","first-page":"3826","DOI":"10.1038\/s41467-018-06152-x","article-title":"LNMAT1 promotes lymphatic metastasis of bladder cancer via CCL2 dependent macrophage recruitment","volume":"9","author":"Chen","year":"2018","journal-title":"Nat. Commun."},{"key":"B23","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/1476-4598-7-78","article-title":"Signal transducer and activator of transcription 3 activation is associated with bladder cancer cell growth and survival","volume":"7","author":"Chen","year":"2008","journal-title":"Mol. Cancer"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e61901","DOI":"10.1371\/journal.pone.0061901","article-title":"IL-6 expression regulates tumorigenicity and correlates with prognosis in bladder cancer","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS One"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.3892\/mmr.2014.2366","article-title":"Transforming growth factor-\u03b21 induces epithelial-mesenchymal transition and increased expression of matrix metalloproteinase-16 via miR-200b downregulation in bladder cancer cells","volume":"10","author":"Chen","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.3390\/diagnostics12081801","article-title":"A diagnostic gene expression signature for bladder cancer can stratify cases into prescribed molecular subtypes and predict outcome","volume":"12","author":"Chen","year":"2022","journal-title":"Diagn. (Basel)"},{"key":"B27","first-page":"1519","article-title":"Loss of E-cadherin expression in bladder cancer is associated with IL6-STAT3 signaling pathway activation","volume":"13","author":"Chen","year":"2020","journal-title":"Int. J. Clin. Exp. Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1093\/annonc\/mdq739","article-title":"Overexpression of CXCL1 and its receptor CXCR2 promote tumor invasion in gastric cancer","volume":"22","author":"Cheng","year":"2011","journal-title":"Ann. Oncol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.cyto.2012.04.017","article-title":"Autocrine CCL2 promotes cell migration and invasion via PKC activation and tyrosine phosphorylation of paxillin in bladder cancer cells","volume":"59","author":"Chiu","year":"2012","journal-title":"Cytokine"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e30206","DOI":"10.1371\/journal.pone.0030206","article-title":"p63 expression defines a lethal subset of muscle-invasive bladder cancers","volume":"7","author":"Choi","year":"2012","journal-title":"PLoS One"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1158\/2326-6066.CIR-14-0160","article-title":"Chemokines in cancer","volume":"2","author":"Chow","year":"2014","journal-title":"Cancer Immunol. Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.3389\/fimmu.2019.02806","article-title":"BCG-induced cross-protection and development of trained immunity: Implication for vaccine design","volume":"10","author":"Covi\u00e1n","year":"2019","journal-title":"Front. Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"4930","DOI":"10.1182\/blood-2013-02-486217","article-title":"Mast cell and macrophage chemokines CXCL1\/CXCL2 control the early stage of neutrophil recruitment during tissue inflammation","volume":"121","author":"De Filippo","year":"2013","journal-title":"Blood"},{"key":"B34","doi-asserted-by":"publisher","first-page":"8632","DOI":"10.4081\/jbr.2020.8632","article-title":"Elevated levels of proinflammatory and anti-inflammatory cytokines in patients with bladder cancer depending on a tumor stage","volume":"93","author":"Dmytryk","year":"2020","journal-title":"J. Biol. Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"611","DOI":"10.2147\/CMAR.S148856","article-title":"Prognostic value of site-specific metastases and therapeutic roles of surgery for patients with metastatic bladder cancer: A population-based study","volume":"9","author":"Dong","year":"2017","journal-title":"Cancer Manag. Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1186\/s12935-021-02314-y","article-title":"Comprehensive analysis of CXCL12 expression reveals the significance of inflammatory fibroblasts in bladder cancer carcinogenesis and progression","volume":"21","author":"Du","year":"2021","journal-title":"Cancer Cell Int."},{"key":"B37","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1186\/s12935-021-01896-x","article-title":"The cancer-associated fibroblasts related gene CALD1 is a prognostic biomarker and correlated with immune infiltration in bladder cancer","volume":"21","author":"Du","year":"2021","journal-title":"Cancer Cell Int."},{"key":"B38","doi-asserted-by":"publisher","first-page":"683951","DOI":"10.3389\/fonc.2021.683951","article-title":"The epithelial to mesenchymal transition related gene calumenin is an adverse prognostic factor of bladder cancer correlated with tumor microenvironment remodeling, gene mutation, and ferroptosis","volume":"11","author":"Du","year":"2021","journal-title":"Front. Oncol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/s0885-3924(00)00199-8","article-title":"Cytokines and advanced cancer","volume":"20","author":"Dunlop","year":"2000","journal-title":"J. Pain Symptom Manage."},{"key":"B40","doi-asserted-by":"publisher","first-page":"E1253","DOI":"10.3390\/cancers12051253","article-title":"CCL2 expression in tumor cells and tumor-infiltrating immune cells shows divergent prognostic potential for bladder cancer patients depending on lymph node stage","volume":"12","author":"Eckstein","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1038\/bjc.1997.299","article-title":"Expression of transforming growth factors beta-1, beta 2 and beta 3 in human bladder carcinomas","volume":"75","author":"Eder","year":"1997","journal-title":"Br. J. Cancer"},{"key":"B42","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1097\/00005392-199609000-00029","article-title":"Transforming growth factors-beta 1 and beta 2 in serum and urine from patients with bladder carcinoma","volume":"156","author":"Eder","year":"1996","journal-title":"J. Urology"},{"key":"B43","doi-asserted-by":"publisher","first-page":"206","DOI":"10.5152\/tud.2020.19186","article-title":"Role of serum and urine transforming growth factor beta 1, matrix metallopeptidase 9, tissue inhibitor of metalloproteinase 2, and nerve growth factor beta levels and serum neutrophil-to-lymphocyte ratio in predicting recurrence and progression risks in patients with primary non-muscle invasive bladder cancer","volume":"46","author":"Efilo\u011flu","year":"2020","journal-title":"Turk. J. Urol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.taap.2011.10.002","article-title":"Interleukin-8 (IL-8) over-production and autocrine cell activation are key factors in monomethylarsonous acid [MMA(III)]-induced malignant transformation of urothelial cells","volume":"258","author":"Escudero-Lourdes","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"622995","DOI":"10.3389\/fimmu.2021.622995","article-title":"Natural killer anti-tumor activity can Be achieved by in vitro incubation with heat-killed BCG","volume":"12","author":"Esteso","year":"2021","journal-title":"Front. Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3389\/fimmu.2013.00138","article-title":"The dendritic cell response to classic, emerging, and homeostatic danger signals. Implications for autoimmunity","volume":"4","author":"Gallo","year":"2013","journal-title":"Front. Immunol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1093\/annonc\/mdr156","article-title":"Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma","volume":"23","author":"Galsky","year":"2012","journal-title":"Ann. Oncol."},{"key":"B48","doi-asserted-by":"crossref","DOI":"10.21203\/rs.2.18542\/v1","volume-title":"CCL2 is associated with metastasis and poor prognosis of bladder cancer","author":"Gao","year":"2019"},{"key":"B49","doi-asserted-by":"publisher","first-page":"5700","DOI":"10.18632\/oncotarget.2144","article-title":"Loss of PPM1A expression enhances invasion and the epithelial-to-mesenchymal transition in bladder cancer by activating the TGF-\u03b2\/Smad signaling pathway","volume":"5","author":"Geng","year":"2014","journal-title":"Oncotarget"},{"key":"B50","doi-asserted-by":"publisher","first-page":"re8","DOI":"10.1126\/scisignal.2005189","article-title":"Signaling mechanisms of the epithelial-mesenchymal transition","volume":"7","author":"Gonzalez","year":"2014","journal-title":"Sci. Signal."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1000245","DOI":"10.15761\/crt.1000245","article-title":"The role of IL-8 in the immune response associated to cancer development","volume":"5","author":"Gonzalez-Aparicio","year":"2018","journal-title":"Clin. Res. Trial."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1016\/j.juro.2013.11.053","article-title":"Differential expression of SDF-1 isoforms in bladder cancer","volume":"191","author":"Gosalbez","year":"2014","journal-title":"J. Urol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12885-019-5353-6","article-title":"Cancer-associated fibroblasts induce epithelial-mesenchymal transition of bladder cancer cells through paracrine IL-6 signalling","volume":"19","author":"Goulet","year":"2019","journal-title":"BMC Cancer"},{"key":"B54","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41416-018-0333-1","article-title":"Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression","volume":"120","author":"Groth","year":"2019","journal-title":"Br. J. Cancer"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.ajpath.2016.01.008","article-title":"Transforming growth factor-\u03b2 is an upstream regulator of mammalian target of rapamycin complex 2-dependent bladder cancer cell migration and invasion","volume":"186","author":"Gupta","year":"2016","journal-title":"Am. J. Pathol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"110393","DOI":"10.1016\/j.biopha.2020.110393","article-title":"Mechanisms of BCG in the treatment of bladder cancer-current understanding and the prospect","volume":"129","author":"Han","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"B57","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1046\/j.1442-2042.2000.00190.x","article-title":"Prognostic value of tumor-associated macrophage count in human bladder cancer","volume":"7","author":"Hanada","year":"2000","journal-title":"Int. J. Urol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"0","DOI":"10.21608\/jcbr.2021.66740.1188","article-title":"Role of tumor-associated macrophages in relation to angiogenesis in urothelial bladder carcinoma","volume":"5","author":"Harras","year":"2021","journal-title":"Int. J. Cancer Biomed. Res."},{"key":"B59","doi-asserted-by":"publisher","first-page":"a022061","DOI":"10.1101\/cshperspect.a022061","article-title":"TGF-\u0392 signaling from receptors to smads","volume":"8","author":"Hata","year":"2016","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1016\/j.febslet.2012.02.037","article-title":"Regulation of EMT by TGF\u03b2 in cancer","volume":"586","author":"Heldin","year":"2012","journal-title":"FEBS Lett."},{"key":"B61","first-page":"34","article-title":"The role of TGF-beta-1 protein and TGF-beta-R-1 receptor in immune escape mechanism in bladder cancer","volume":"9","author":"Helmy","year":"2007","journal-title":"MedGenMed."},{"key":"B62","doi-asserted-by":"publisher","first-page":"105042","DOI":"10.1016\/j.archoralbio.2021.105042","article-title":"M2-like macrophage infiltration and transforming growth factor-\u03b2 secretion during socket healing process in mice","volume":"123","author":"Horibe","year":"2021","journal-title":"Arch. Oral Biol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.7150\/thno.53649","article-title":"Siglec15 shapes a non-inflamed tumor microenvironment and predicts the molecular subtype in bladder cancer","volume":"11","author":"Hu","year":"2021","journal-title":"Theranostics"},{"key":"B64","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.21873\/anticanres.14243","article-title":"Tumor-associated macrophages facilitate bladder cancer progression by increasing cell growth, migration, invasion and cytokine expression","volume":"40","author":"Huang","year":"2020","journal-title":"Anticancer Res."},{"key":"B65","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1111\/febs.14466","article-title":"A guide to chemokines and their receptors","volume":"285","author":"Hughes","year":"2018","journal-title":"Febs J."},{"key":"B66","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/1878-0261.12397","article-title":"BCG-induced cytokine release in bladder cancer cells is regulated by Ca(2+) signaling","volume":"13","author":"Ibarra","year":"2019","journal-title":"Mol. Oncol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1158\/1078-0432.CCR-16-1417","article-title":"Atezolizumab: A PD-L1-blocking antibody for bladder cancer","volume":"23","author":"Inman","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"B68","first-page":"2290","article-title":"Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer","volume":"60","author":"Inoue","year":"2000","journal-title":"Cancer Res."},{"key":"B69","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s10555-006-9006-2","article-title":"Transforming growth factor-beta in cancer and metastasis","volume":"25","author":"Jakowlew","year":"2006","journal-title":"Cancer Metastasis Rev."},{"key":"B70","doi-asserted-by":"publisher","first-page":"722916","DOI":"10.3389\/fonc.2021.722916","article-title":"CCL2: An important mediator between tumor cells and host cells in tumor microenvironment","volume":"11","author":"Jin","year":"2021","journal-title":"Front. Oncol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"E217","DOI":"10.3390\/cells9010217","article-title":"Role of JAK\/STAT3 signaling in the regulation of metastasis, the transition of cancer stem cells, and chemoresistance of cancer by epithelial-mesenchymal transition","volume":"9","author":"Jin","year":"2020","journal-title":"Cells"},{"key":"B72","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3389\/fonc.2015.00155","article-title":"Implications of the hybrid epithelial\/mesenchymal phenotype in metastasis","volume":"5","author":"Jolly","year":"2015","journal-title":"Front. Oncol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1530\/REP-09-0341","article-title":"Interleukin-8 (CXCL8) stimulates trophoblast cell migration and invasion by increasing levels of matrix metalloproteinase (MMP)2 and MMP9 and integrins alpha5 and beta1","volume":"139","author":"Jovanovi\u0107","year":"2010","journal-title":"Reproduction"},{"key":"B74","doi-asserted-by":"publisher","first-page":"11450","DOI":"10.18632\/oncotarget.7199","article-title":"Frequency of CD4+CD25+Foxp3+ cells in peripheral blood in relation to urinary bladder cancer malignancy indicators before and after surgical removal","volume":"7","author":"J\u00f3\u017awicki","year":"2016","journal-title":"Oncotarget"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial-mesenchymal transition","volume":"119","author":"Kalluri","year":"2009","journal-title":"J. Clin. Invest."},{"key":"B76","doi-asserted-by":"publisher","first-page":"9","DOI":"10.5152\/tud.2017.60376","article-title":"What is new in non-muscle-invasive bladder cancer in 2016?","volume":"43","author":"Kamat","year":"2017","journal-title":"Turk. J. Urol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"692142","DOI":"10.3389\/fonc.2021.692142","article-title":"Tumor-induced inflammatory cytokines and the emerging diagnostic devices for cancer detection and prognosis","volume":"11","author":"Kartikasari","year":"2021","journal-title":"Front. Oncol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1158\/1078-0432.CCR-07-1922","article-title":"Secreted CXCL1 is a potential mediator and marker of the tumor invasion of bladder cancer","volume":"14","author":"Kawanishi","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1002\/1097-0142(20010915)92:6<1475:aid-cncr1472>3.0.co;2-x","article-title":"Predictive value of expression of transforming growth factor-beta(1) and its receptors in transitional cell carcinoma of the urinary bladder","volume":"92","author":"Kim","year":"2001","journal-title":"Cancer"},{"key":"B80","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.clinbiochem.2004.02.005","article-title":"Determination of diagnostic and prognostic values of urinary interleukin-8, tumor necrosis factor-\u03b1, and leukocyte arylsulfatase-A activity in patients with bladder cancer","volume":"37","author":"Ko\u00e7ak","year":"2004","journal-title":"Clin. Biochem."},{"key":"B81","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41417-021-00303-x","article-title":"Key chemokines direct migration of immune cells in solid tumors","volume":"29","author":"Kohli","year":"2022","journal-title":"Cancer Gene Ther."},{"key":"B82","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3233\/CLO-2009-0501","article-title":"Novel in vitro assays for the characterization of EMT in tumourigenesis","volume":"32","author":"Koo","year":"2010","journal-title":"Cell. Oncol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"233","DOI":"10.5301\/uro.5000063","article-title":"Impact of NK cell count on bladder cancer recurrence","volume":"81","author":"Krpina","year":"2014","journal-title":"Urologia"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1010428317697552","DOI":"10.1177\/1010428317697552","article-title":"Predictive role of serum and urinary cytokines in invasion and recurrence of bladder cancer","volume":"39","author":"Kumari","year":"2017","journal-title":"Tumour Biol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"381428","DOI":"10.5402\/2012\/381428","article-title":"The dual role of TGF\u03b2 in human cancer: From tumor suppression to cancer metastasis","volume":"2012","author":"Lebrun","year":"2012","journal-title":"ISRN Mol. Biol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"e54073","DOI":"10.1371\/journal.pone.0054073","article-title":"Activation of thromboxane A2 receptor (TP) increases the expression of monocyte chemoattractant protein -1 (MCP-1)\/Chemokine (C-C motif) ligand 2 (CCL2) and recruits macrophages to promote invasion of lung cancer cells","volume":"8","author":"Li","year":"2013","journal-title":"PLOS ONE"},{"key":"B87","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s12894-021-00938-w","article-title":"Identification of prognostic and therapeutic value of CC chemokines in urothelial bladder cancer: Evidence from comprehensive bioinformatic analysis","volume":"21","author":"Li","year":"2021","journal-title":"BMC Urol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/j.1365-2249.2004.02523.x","article-title":"CD56(+dim) and CD56(+bright) cell activation and apoptosis in hepatitis C virus infection","volume":"137","author":"Lin","year":"2004","journal-title":"Clin. Exp. Immunol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"636870","DOI":"10.3389\/fonc.2021.636870","article-title":"CXCL12 and CD3E as indicators for tumor microenvironment modulation in bladder cancer and their correlations with immune infiltration and molecular subtypes","volume":"11","author":"Liu","year":"2021","journal-title":"Front. Oncol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41419-019-1581-6","article-title":"Cancer-associated fibroblasts promote cisplatin resistance in bladder cancer cells by increasing IGF-1\/ER\u03b2\/Bcl-2 signalling","volume":"10","author":"Long","year":"2019","journal-title":"Cell Death Dis."},{"key":"B91","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.devcel.2019.04.010","article-title":"Epithelial-mesenchymal plasticity in cancer progression and metastasis","volume":"49","author":"Lu","year":"2019","journal-title":"Dev. Cell"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.3389\/fimmu.2020.01156","article-title":"B lymphocytes as targets of the immunomodulatory properties of human amniotic mesenchymal stromal cells","volume":"11","author":"Magatti","year":"2020","journal-title":"Front. Immunol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.3389\/fimmu.2019.01306","article-title":"Role of dendritic cells in natural immune control of HIV-1 infection","volume":"10","author":"Martin-Gayo","year":"2019","journal-title":"Front. Immunol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s13402-021-00657-2","article-title":"Cadherin switches during epithelial-mesenchymal transition: CDH4\/RCAD downregulation reduces bladder cancer progression","volume":"45","author":"Martins-Lima","year":"2022","journal-title":"Cell. Oncol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11912-018-0727-5","article-title":"Molecular subtypes of bladder cancer","volume":"20","author":"McConkey","year":"2018","journal-title":"Curr. Oncol. Rep."},{"key":"B96","first-page":"3167","article-title":"Fully human anti-interleukin 8 antibody inhibits tumor growth in orthotopic bladder cancer xenografts via down-regulation of matrix metalloproteases and nuclear factor-kappaB","volume":"9","author":"Mian","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"B97","doi-asserted-by":"publisher","first-page":"5670","DOI":"10.3390\/ijms21165670","article-title":"Evolution of urothelial bladder cancer in the context of molecular classifications","volume":"21","author":"Minoli","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B98","doi-asserted-by":"publisher","first-page":"853","DOI":"10.7150\/thno.29553","article-title":"Monoclonal antibody against CXCL1 (HL2401) as a novel agent in suppressing IL6 expression and tumoral growth","volume":"9","author":"Miyake","year":"2019","journal-title":"Theranostics"},{"key":"B99","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.neo.2016.08.002","article-title":"CXCL1-Mediated interaction of cancer cells with tumor-associated macrophages and cancer-associated fibroblasts promotes tumor progression in human bladder cancer","volume":"18","author":"Miyake","year":"2016","journal-title":"Neoplasia"},{"key":"B100","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/1471-2407-13-322","article-title":"Chemokine (C-X-C) ligand 1 (CXCL1) protein expression is increased in aggressive bladder cancers","volume":"13","author":"Miyake","year":"2013","journal-title":"BMC Cancer"},{"key":"B101","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1002\/1097-0142(19950515)75:10<2565:aid-cncr2820751025>3.0.co;2-m","article-title":"Expression of transforming growth factor-beta 1 in human bladder cancer","volume":"75","author":"Miyamoto","year":"1995","journal-title":"Cancer"},{"key":"B102","doi-asserted-by":"publisher","first-page":"3689","DOI":"10.1182\/blood-2010-09-303057","article-title":"Dissecting CD56dim human NK cells","volume":"116","author":"Moretta","year":"2010","journal-title":"Blood"},{"key":"B103","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1080\/07357907.2018.1506800","article-title":"Correlation of immune cells and cytokines in the tumor microenvironment with elevated neutrophil-to-lymphocyte ratio in blood: An analysis of muscle-invasive bladder cancer","volume":"36","author":"Morizawa","year":"2018","journal-title":"Cancer Invest."},{"key":"B104","doi-asserted-by":"publisher","first-page":"36492","DOI":"10.18632\/oncotarget.26362","article-title":"Intratumoral CD56(bright) natural killer cells are associated with improved survival in bladder cancer","volume":"9","author":"Mukherjee","year":"2018","journal-title":"Oncotarget"},{"key":"B105","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1016\/j.ucl.2020.10.005","article-title":"The tumor microenvironment and immunotherapy in prostate and bladder cancer","volume":"47","author":"Nair","year":"2020","journal-title":"Urol. Clin. North Am."},{"key":"B106","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/(sici)1097-0215(19970703)72:1<149:aid-ijc21>3.0.co;2-d","article-title":"Interleukin-6 functions as an autocrine growth factor in human bladder carcinoma cell lines in vitro","volume":"72","author":"Okamoto","year":"1997","journal-title":"Int. J. Cancer"},{"key":"B107","doi-asserted-by":"publisher","first-page":"26065","DOI":"10.18632\/oncotarget.4569","article-title":"Tumor microenvironment B cells increase bladder cancer metastasis via modulation of the IL-8\/androgen receptor (AR)\/MMPs signals","volume":"6","author":"Ou","year":"2015","journal-title":"Oncotarget"},{"key":"B108","doi-asserted-by":"publisher","first-page":"587193","DOI":"10.3389\/fimmu.2020.583084","article-title":"Tumor-associated macrophages in tumor immunity","volume":"11","author":"Pan","year":"2020","journal-title":"Front. Immunol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"587193","DOI":"10.1155\/2015\/587193","article-title":"TGF\u03b2 signaling in tumor initiation, epithelial-to-mesenchymal transition, and metastasis","volume":"2015","author":"Papageorgis","year":"2015","journal-title":"J. Oncol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1365-2567.2008.03027.x","article-title":"CD56bright natural killer (NK) cells: An important NK cell subset","volume":"126","author":"Poli","year":"2009","journal-title":"Immunology"},{"key":"B111","doi-asserted-by":"publisher","first-page":"480739","DOI":"10.1155\/2013\/480739","article-title":"Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain","volume":"2013","author":"Ramesh","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"B112","doi-asserted-by":"publisher","first-page":"7842","DOI":"10.18632\/oncotarget.5467","article-title":"Recruited mast cells in the tumor microenvironment enhance bladder cancer metastasis via modulation of ER\u03b2\/CCL2\/CCR2 EMT\/MMP9 signals","volume":"7","author":"Rao","year":"2016","journal-title":"Oncotarget"},{"key":"B113","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1471-2490-12-18","article-title":"Increased expression of MMP-9 and IL-8 are correlated with poor prognosis of Bladder Cancer","volume":"12","author":"Reis","year":"2012","journal-title":"BMC Urol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/ijc.20729","article-title":"CXCR4 expression reflects tumor progression and regulates motility of bladder cancer cells","volume":"114","author":"Retz","year":"2005","journal-title":"Int. J. Cancer"},{"key":"B115","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1158\/1078-0432.CCR-14-2291","article-title":"Interleukin-6 as a therapeutic target","volume":"21","author":"Rossi","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"B116","doi-asserted-by":"publisher","first-page":"157","DOI":"10.4081\/aiua.2013.4.157","article-title":"Dendritic cells in blood and urine samples from bladder cancer patients undergoing BCG immunotherapy","volume":"85","author":"Rossi","year":"2013","journal-title":"Arch. Ital. Urol. Androl."},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-022-04262-0","article-title":"PD-1, PD-L1 and cAMP immunohistochemical expressions are associated with worse oncological outcome in patients with bladder cancer","author":"Russo","year":"2022","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"33123","DOI":"10.1038\/srep33123","article-title":"Chemokine CXCL1 mediated neutrophil recruitment: Role of glycosaminoglycan interactions","volume":"6","author":"Sawant","year":"2016","journal-title":"Sci. Rep."},{"key":"B119","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00262-021-02953-0","article-title":"Impact of preoperative plasma levels of interleukin 6 and interleukin 6 soluble receptor on disease outcomes after radical cystectomy for bladder cancer","volume":"71","author":"Schuettfort","year":"2022","journal-title":"Cancer Immunol. Immunother."},{"key":"B120","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1002\/1097-0142(20011215)92:12<2985:aid-cncr10175>3.0.co;2-5","article-title":"Preoperative plasma levels of transforming growth factor beta(1) strongly predict clinical outcome in patients with bladder carcinoma","volume":"92","author":"Shariat","year":"2001","journal-title":"Cancer"},{"key":"B121","doi-asserted-by":"publisher","first-page":"101985","DOI":"10.1016\/j.isci.2020.101985","article-title":"Engineering approaches for studying immune-tumor cell interactions and immunotherapy","volume":"24","author":"Shelton","year":"2021","journal-title":"iScience"},{"key":"B122","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1007\/s13277-013-0725-z","article-title":"CXCR4-mediated Stat3 activation is essential for CXCL12-induced cell invasion in bladder cancer","volume":"34","author":"Shen","year":"2013","journal-title":"Tumour Biol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"E1561","DOI":"10.3390\/biom10111561","article-title":"Emerging concepts of hybrid epithelial-to-mesenchymal transition in cancer progression","volume":"10","author":"Sinha","year":"2020","journal-title":"Biomolecules"},{"key":"B124","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.cytogfr.2017.05.008","article-title":"Deciphering the loop of epithelial-mesenchymal transition, inflammatory cytokines and cancer immunoediting","volume":"36","author":"Sistigu","year":"2017","journal-title":"Cytokine Growth Factor Rev."},{"key":"B125","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.urolonc.2014.02.007","article-title":"Infiltration of CD3\u207a and CD68\u207a cells in bladder cancer is subtype specific and affects the outcome of patients with muscle-invasive tumors","volume":"32","author":"Sj\u00f6dahl","year":"2014","journal-title":"Urol. Oncol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"a016303","DOI":"10.1101\/cshperspect.a016303","article-title":"The chemokine system in innate immunity","volume":"7","author":"Sokol","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/path.5306","article-title":"Bladder cancer, a unique model to understand cancer immunity and develop immunotherapy approaches","volume":"249","author":"Song","year":"2019","journal-title":"J. Pathol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"100405","DOI":"10.1016\/j.jbo.2021.100405","article-title":"Bone metastases from urothelial carcinoma. The dark side of the moon","volume":"31","author":"Stellato","year":"2021","journal-title":"J. Bone Oncol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"E302","DOI":"10.3390\/medicina55060302","article-title":"Prognostic impact of canonical TGF-\u03b2 signaling in urothelial bladder cancer","volume":"55","author":"Stojnev","year":"2019","journal-title":"Med. Kaunas."},{"key":"B130","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1002\/1878-0261.12095","article-title":"EMT and inflammation: Inseparable actors of cancer progression","volume":"11","author":"Suarez-Carmona","year":"2017","journal-title":"Mol. Oncol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"6262","DOI":"10.3934\/mbe.2021313","article-title":"Exploration of prognostic biomarkers and therapeutic targets in the microenvironment of bladder cancer based on CXC chemokines","volume":"18","author":"Sun","year":"2021","journal-title":"Math. Biosci. Eng."},{"key":"B132","doi-asserted-by":"publisher","first-page":"724107","DOI":"10.3389\/fimmu.2021.724107","article-title":"A transcriptional signature of IL-2 expanded natural killer cells predicts more favorable prognosis in bladder cancer","volume":"12","author":"Sun","year":"2021","journal-title":"Front. Immunol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1158\/2326-6066.CIR-15-0274","article-title":"Molecular drivers of the non-T-cell-inflamed tumor microenvironment in urothelial bladder cancer","volume":"4","author":"Sweis","year":"2016","journal-title":"Cancer Immunol. Res."},{"key":"B134","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.3892\/ol.2016.4392","article-title":"Predominance of M2-polarized macrophages in bladder cancer affects angiogenesis, tumor grade and invasiveness","volume":"11","author":"Takeuchi","year":"2016","journal-title":"Oncol. Lett."},{"key":"B135","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.canlet.2020.03.013","article-title":"Myeloid-derived suppressor cells are essential partners for immune checkpoint inhibitors in the treatment of cisplatin-resistant bladder cancer","volume":"479","author":"Takeyama","year":"2020","journal-title":"Cancer Lett."},{"key":"B136","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.immuni.2020.03.001","article-title":"CXCR1 and CXCR2 chemokine receptor agonists produced by tumors induce neutrophil extracellular traps that interfere with immune cytotoxicity","volume":"52","author":"Teijeira","year":"2020","journal-title":"Immunity"},{"key":"B137","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1158\/2326-6066.CIR-18-0277","article-title":"T cell-inflamed versus non-T cell-inflamed tumors: A conceptual framework for cancer immunotherapy drug development and combination therapy selection","volume":"6","author":"Trujillo","year":"2018","journal-title":"Cancer Immunol. Res."},{"key":"B138","doi-asserted-by":"publisher","first-page":"F816","DOI":"10.1152\/ajprenal.90733.2008","article-title":"Interleukin-8 is essential for normal urothelial cell survival","volume":"297","author":"Tseng-Rogenski","year":"2009","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"791212","DOI":"10.1155\/2013\/791212","article-title":"Mechanisms by which interleukin-6 attenuates cell invasion and tumorigenesis in human bladder carcinoma cells","volume":"2013","author":"Tsui","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"B140","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1471-2490-12-12","article-title":"IL-8 as a urinary biomarker for the detection of bladder cancer","volume":"12","author":"Urquidi","year":"2012","journal-title":"BMC Urol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1093\/cvr\/cvu062","article-title":"Crosstalk between fibroblasts and inflammatory cells","volume":"102","author":"Van Linthout","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"B142","doi-asserted-by":"publisher","first-page":"e1402","DOI":"10.1002\/cti2.1402","article-title":"Detailed bladder cancer immunoprofiling reveals new clues for immunotherapeutic strategies","volume":"11","author":"Viveiros","year":"2022","journal-title":"Clin. Transl. Immunol."},{"key":"B143","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/s41419-018-0876-3","article-title":"CXCL1 derived from tumor-associated macrophages promotes breast cancer metastasis via activating NF-\u03baB\/SOX4 signaling","volume":"9","author":"Wang","year":"2018","journal-title":"Cell Death Dis."},{"key":"B144","doi-asserted-by":"publisher","first-page":"9293","DOI":"10.1002\/cam4.3560","article-title":"The role of surgery on the primary tumor site in bladder cancer with distant metastasis: Significance of histology type and metastatic pattern","volume":"9","author":"Wang","year":"2020","journal-title":"Cancer Med."},{"key":"B145","doi-asserted-by":"publisher","first-page":"1010428317698383","DOI":"10.1177\/1010428317698383","article-title":"MiR-1-3p inhibits the proliferation and invasion of bladder cancer cells by suppressing CCL2 expression","volume":"39","author":"Wang","year":"2017","journal-title":"Tumour Biol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41577-019-0210-z","article-title":"Dendritic cells in cancer immunology and immunotherapy","volume":"20","author":"Wculek","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"B147","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.2217\/fon.09.90","article-title":"Mechanisms of the epithelial-mesenchymal transition by TGF-beta","volume":"5","author":"Wendt","year":"2009","journal-title":"Future Oncol."},{"key":"B148","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1111\/j.1464-410X.2010.10020.x","article-title":"FOXP3 and survival in urinary bladder cancer","volume":"108","author":"Winerdal","year":"2011","journal-title":"BJU Int."},{"key":"B149","doi-asserted-by":"publisher","first-page":"E1181","DOI":"10.3390\/cancers12051181","article-title":"Immunotherapy in bladder cancer: Current methods and future perspectives","volume":"12","author":"Wo\u0142\u0105cewicz","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B150","doi-asserted-by":"publisher","first-page":"63204","DOI":"10.18632\/oncotarget.11434","article-title":"Immunosuppressive effect of bladder cancer on function of dendritic cells involving of Jak2\/STAT3 pathway","volume":"7","author":"Xiu","year":"2016","journal-title":"Oncotarget"},{"key":"B151","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/cr.2009.5","article-title":"TGF-beta-induced epithelial to mesenchymal transition","volume":"19","author":"Xu","year":"2009","journal-title":"Cell Res."},{"key":"B152","doi-asserted-by":"publisher","first-page":"e13115","DOI":"10.1111\/cpr.13115","article-title":"Role of the CCL2-CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting","volume":"54","author":"Xu","year":"2021","journal-title":"Cell Prolif."},{"key":"B153","doi-asserted-by":"publisher","first-page":"409","DOI":"10.5489\/cuaj.1156","article-title":"Radical cystectomy is the treatment of choice for invasive bladder cancer","volume":"3","author":"Yafi","year":"2009","journal-title":"Can. Urological Assoc. J. = J. de l'Association des urologues du Can."},{"key":"B154","doi-asserted-by":"publisher","first-page":"17699","DOI":"10.4238\/2015.December.21.43","article-title":"Chemokine receptor CXCR4 and its ligand CXCL12 expressions and clinical significance in bladder cancer","volume":"14","author":"Yang","year":"2015","journal-title":"Genet. Mol. Res."},{"key":"B155","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1111\/jcmm.17257","article-title":"Occludin facilitates tumour angiogenesis in bladder cancer by regulating IL8\/STAT3 through STAT4","volume":"26","author":"Yang","year":"2022","journal-title":"J. Cell. Mol. Med."},{"key":"B156","doi-asserted-by":"publisher","first-page":"38378","DOI":"10.18632\/oncotarget.16386","article-title":"Accumulation of myeloid-derived suppressor cells (MDSCs) induced by low levels of IL-6 correlates with poor prognosis in bladder cancer","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"key":"B157","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1111\/jcmm.13442","article-title":"GP73 promotes invasion and metastasis of bladder cancer by regulating the epithelial-mesenchymal transition through the TGF-\u03b21\/Smad2 signalling pathway","volume":"22","author":"Yang","year":"2018","journal-title":"J. Cell. Mol. Med."},{"key":"B158","doi-asserted-by":"publisher","first-page":"7282","DOI":"10.18632\/aging.103076","article-title":"HMGN5 promotes IL-6-induced epithelial-mesenchymal transition of bladder cancer by interacting with Hsp27","volume":"12","author":"Yao","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"B159","first-page":"1146","article-title":"Fibroblast ER\u03b1 promotes bladder cancer invasion via increasing the CCL1 and IL-6 signals in the tumor microenvironment","volume":"5","author":"Yeh","year":"2015","journal-title":"Am. J. Cancer Res."},{"key":"B160","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat. Commun."},{"key":"B161","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/bjc.2013.768","article-title":"Cancer-associated fibroblasts induce epithelial\u2013mesenchymal transition of breast cancer cells through paracrine TGF-\u03b2 signalling","volume":"110","author":"Yu","year":"2014","journal-title":"Br. J. Cancer"},{"key":"B162","doi-asserted-by":"publisher","first-page":"645","DOI":"10.4111\/kju.2013.54.10.645","article-title":"Role of the epithelial-mesenchymal transition in bladder cancer: From prognosis to therapeutic target","volume":"54","author":"Yun","year":"2013","journal-title":"Korean J. Urol."},{"key":"B163","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/AIA.0b013e318034194e","article-title":"Cytokines, inflammation, and pain","volume":"45","author":"Zhang","year":"2007","journal-title":"Int. Anesthesiol. Clin."},{"key":"B164","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/B978-0-12-385071-3.00003-4","article-title":"Targeting chemokine (C-C motif) ligand 2 (CCL2) as an example of translation of cancer molecular biology to the clinic","volume":"95","author":"Zhang","year":"2010","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"B165","doi-asserted-by":"publisher","first-page":"977","DOI":"10.3892\/or.2016.4889","article-title":"TGF-\u03b21 promotes the migration and invasion of bladder carcinoma cells by increasing fascin1 expression","volume":"36","author":"Zhang","year":"2016","journal-title":"Oncol. Rep."},{"key":"B166","doi-asserted-by":"publisher","first-page":"e3921","DOI":"10.7717\/peerj.3921","article-title":"Tumor-infiltrating CD8+ lymphocytes predict different clinical outcomes in organ- and non-organ-confined urothelial carcinoma of the bladder following radical cystectomy","volume":"5","author":"Zhang","year":"2017","journal-title":"PeerJ"},{"key":"B167","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.3892\/or.2018.6546","article-title":"Suppression of the SDF-1\/CXCR4\/\u03b2-catenin axis contributes to bladder cancer cell growth inhibition in vitro and in vivo","volume":"40","author":"Zhang","year":"2018","journal-title":"Oncol. Rep."},{"key":"B168","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s12885-020-06740-5","article-title":"In silico analysis of the immune microenvironment in bladder cancer","volume":"20","author":"Zhang","year":"2020","journal-title":"BMC Cancer"},{"key":"B169","doi-asserted-by":"publisher","first-page":"111693","DOI":"10.1016\/j.ecoenv.2020.111693","article-title":"HER2 overexpression triggers the IL-8 to promote arsenic-induced EMT and stem cell-like phenotypes in human bladder epithelial cells","volume":"208","author":"Zhou","year":"2021","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"B170","doi-asserted-by":"publisher","first-page":"6995","DOI":"10.2147\/CMAR.S208984","article-title":"Secreted TGF-beta-induced protein promotes aggressive progression in bladder cancer cells","volume":"11","author":"Zou","year":"2019","journal-title":"Cancer Manag. Res."}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2022.1070383\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T08:51:58Z","timestamp":1673254318000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2022.1070383\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,9]]},"references-count":170,"alternative-id":["10.3389\/fmolb.2022.1070383"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2022.1070383","relation":{},"ISSN":["2296-889X"],"issn-type":[{"value":"2296-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,9]]},"article-number":"1070383"}}